Diflunisal

• CAT Number: A000051
• CAS Number: 22494-42-4
• Molecular Formula: C13H8F2O3
• Molecular Weight: 250.201
• Purity: ≥95%
• Target: COX
• Solubility: Soluble in DMSO
• Storage: Store at -20°C
• IUPAC Name: 5-(2,4-difluorophenyl)-2-hydroxybenzoic acid
• InChI: InChI=1S/C13H8F2O3/c14-8-2-3-9(11(15)6-8)7-1-4-12(16)10(5-7)13(17)18/h1-6,16H,(H,17,18)
• InChIKey: HUPFGZXOMWLGNK-UHFFFAOYSA-N
• SMILES: C1=CC(=C(C=C1C2=C(C=C(C=C2)F)F)C(=O)O)O

Diflunisal is a salicylic acid derivative with analgesic and anti-inflammatory activity. It was developed by Merck Sharp & Dohme in 1971 after showing promise in a research project studying more potent chemical analogs of aspirin. It was first sold under the brand name Dolobid, marketed by Merck & Co., but generic versions are now widely available. It is classed as a non-steroidal anti-inflammatory drug (NSAID).

Reference

1: Kaur A, Bhoop BS, Chhibber S, Sharma G, Gondil VS, Katare OP. Supramolecular
nano-engineered lipidic carriers based on diflunisal-phospholipid complex for
transdermal delivery: QbD based optimization, characterization and preclinical
investigations for management of rheumatoid arthritis. Int J Pharm. 2017 Nov
25;533(1):206-224. doi: 10.1016/j.ijpharm.2017.09.041. Epub 2017 Sep 21. PubMed
PMID: 28943207.

2: Duret G, Pereira FA, Raphael RM. Diflunisal inhibits prestin by
chloride-dependent mechanism. PLoS One. 2017 Aug 17;12(8):e0183046. doi:
10.1371/journal.pone.0183046. eCollection 2017. PubMed PMID: 28817613; PubMed
Central PMCID: PMC5560734.

3: Pandey P, Verma V, Gautam G, Kumari N, Dhar SK, Gourinath S. Targeting the
β-clamp in Helicobacter pylori with FDA-approved drugs reveals micromolar
inhibition by diflunisal. FEBS Lett. 2017 Aug;591(15):2311-2322. doi:
10.1002/1873-3468.12734. Epub 2017 Jul 26. PubMed PMID: 28656718.

4: Pallipurath AR, Civati F, Sibik J, Crowley C, Zeitler JA, McArdle P, Erxleben
A. A comprehensive spectroscopic study of the polymorphs of diflunisal and their
phase transformations. Int J Pharm. 2017 Aug 7;528(1-2):312-321. doi:
10.1016/j.ijpharm.2017.06.020. Epub 2017 Jun 8. PubMed PMID: 28603011.

5: Azorín SE, Cabib CE, Campistol JM. Diflunisal compassive use in transthyretin
hereditary amyloid polyneuropathy: report of a first Spanish experience. Amyloid.
2017 Mar;24(sup1):105-106. doi: 10.1080/13506129.2017.1291424. PubMed PMID:
28434315.

6: Tarushi A, Kakoulidou C, Raptopoulou CP, Psycharis V, Kessissoglou DP, Zoi I,
Papadopoulos AN, Psomas G. Zinc complexes of diflunisal: Synthesis,
characterization, structure, antioxidant activity, and in vitro and in silico
study of the interaction with DNA and albumins. J Inorg Biochem. 2017
May;170:85-97. doi: 10.1016/j.jinorgbio.2017.02.010. Epub 2017 Feb 12. PubMed
PMID: 28231454.

7: Kaur A, Goindi S, Katare OP. Formulation, characterisation and in vivo
evaluation of lipid-based nanocarrier for topical delivery of diflunisal. J
Microencapsul. 2016 Aug;33(5):475-86. doi: 10.1080/02652048.2016.1216189. Epub
2016 Aug 8. PubMed PMID: 27499126.

8: Hendrix AS, Spoonmore TJ, Wilde AD, Putnam NE, Hammer ND, Snyder DJ, Guelcher
SA, Skaar EP, Cassat JE. Repurposing the Nonsteroidal Anti-inflammatory Drug
Diflunisal as an Osteoprotective, Antivirulence Therapy for Staphylococcus aureus
Osteomyelitis. Antimicrob Agents Chemother. 2016 Aug 22;60(9):5322-30. doi:
10.1128/AAC.00834-16. Print 2016 Sep. PubMed PMID: 27324764; PubMed Central
PMCID: PMC4997817.

9: Perontsis S, Hatzidimitriou AG, Papadopoulos AN, Psomas G. Nickel-diflunisal
complexes: synthesis, characterization, in vitro antioxidant activity and
interaction with DNA and albumins. J Inorg Biochem. 2016 Sep;162:9-21. doi:
10.1016/j.jinorgbio.2016.06.003. Epub 2016 Jun 4. PubMed PMID: 27318424.

10: Shirakawa K, Wang L, Man N, Maksimoska J, Sorum AW, Lim HW, Lee IS, Shimazu
T, Newman JC, Schröder S, Ott M, Marmorstein R, Meier J, Nimer S, Verdin E.
Salicylate, diflunisal and their metabolites inhibit CBP/p300 and exhibit
anticancer activity. Elife. 2016 May 31;5. pii: e11156. doi: 10.7554/eLife.11156.
PubMed PMID: 27244239; PubMed Central PMCID: PMC4931907.